Inventor · disambiguated record
Susan Sweeney Prohaska
Also filed as: PROHASKA SUSAN SWEENEY
9 granted patents·1 pending application·55 citations·filing 2014–2023
87Inventor score
Files withUNIV LELAND STANFORD JUNIOR10
Top patents by PatentIndex Score
10 records- 0198US11518806B2Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibodyUNIV LELAND STANFORD JUNIOR·Filed 2022·Granted Dec 6, 2022·6 cites·34 claims
- 0297US11136391B2Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibodyUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Oct 5, 2021·9 cites·17 claims
- 0396US11603404B2Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibodyUNIV LELAND STANFORD JUNIOR·Filed 2022·Granted Mar 14, 2023·3 cites·36 claims
- 0496US9623079B2Methods for achieving therapeutically effective doses of anti-CD47 agents for treating cancerUNIV LELAND STANFORD JUNIOR·Filed 2014·Granted Apr 18, 2017·26 cites·12 claims
- 0594US10301387B2Methods for achieving therapeutically effective doses of anti-CD47 agentsUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted May 28, 2019·11 cites·15 claims
- 0686US12258403B2Methods for treating myeloma by achieving therapeutically effective doses of anti-CD47 antibodyUNIV LELAND STANFORD JUNIOR·Filed 2023·Granted Mar 25, 2025·0 cites·19 claims
- 0780US12258399B2Methods for achieving therapeutically effective doses of anti-CD47 agentsUNIV LELAND STANFORD JUNIOR·Filed 2021·Granted Mar 25, 2025·0 cites·18 claims
- 0873US11104731B2Compositions for achieving therapeutically effective doses of anti-CD47 agentsUNIV LELAND STANFORD JUNIOR·Filed 2019·Granted Aug 31, 2021·0 cites·2 claims
- 0963US2023233616A1Hematopoietic Stem Cell EngraftmentUNIV LELAND STANFORD JUNIOR·Filed 2023·Application pending·0 cites
- 1049US11642379B2Hematopoietic stem cell engraftmentUNIV LELAND STANFORD JUNIOR·Filed 2018·Granted May 9, 2023·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Susan Sweeney Prohaska files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →